Trial Outcomes & Findings for Postplacental or Delayed Insertion of the Levonorgestrel-releasing Intrauterine Device (IUD) After Vaginal Delivery (NCT NCT00476021)

NCT ID: NCT00476021

Last Updated: 2016-06-24

Results Overview

Usage rate of the LNG-IUD at 6 months after delivery

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

168 participants

Primary outcome timeframe

6 months after delivery

Results posted on

2016-06-24

Participant Flow

Participant milestones

Participant milestones
Measure
Postplacental IUD Insertion
Postplacental LNG-IUD insertion
Delayed IUD Insertion
Delayed LNG-IUD insertion
Overall Study
STARTED
51
51
Overall Study
COMPLETED
51
51
Overall Study
NOT COMPLETED
0
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Postplacental or Delayed Insertion of the Levonorgestrel-releasing Intrauterine Device (IUD) After Vaginal Delivery

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Immediate Postplacental IUD Insertion
n=51 Participants
immediate postplacental IUD insertion Levonorgestrel-releasing IUD (Mirena): levonorgestrel-releasing IUD containing 52 mg levonorgestrel, indicated for use for up to 5 years
Delayed IUD Insertion (6-8 Weeks After Delivery)
n=51 Participants
delayed IUD insertion (6-8 weeks after delivery) Levonorgestrel-releasing IUD (Mirena): levonorgestrel-releasing IUD containing 52 mg levonorgestrel, indicated for use for up to 5 years
Total
n=102 Participants
Total of all reporting groups
Age, Categorical
<=18 years
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Age, Categorical
Between 18 and 65 years
51 Participants
n=5 Participants
51 Participants
n=7 Participants
102 Participants
n=5 Participants
Age, Categorical
>=65 years
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Age, Continuous
25.4 years
STANDARD_DEVIATION 5.3 • n=5 Participants
24.7 years
STANDARD_DEVIATION 5.2 • n=7 Participants
25.1 years
STANDARD_DEVIATION 5.2 • n=5 Participants
Sex: Female, Male
Female
51 Participants
n=5 Participants
51 Participants
n=7 Participants
102 Participants
n=5 Participants
Sex: Female, Male
Male
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Region of Enrollment
United States
51 participants
n=5 Participants
51 participants
n=7 Participants
102 participants
n=5 Participants
Received IUD per protocol
Received IUD per protocol
50 participants
n=5 Participants
46 participants
n=7 Participants
96 participants
n=5 Participants
Received IUD per protocol
Did not receive IUD per protocol
1 participants
n=5 Participants
5 participants
n=7 Participants
6 participants
n=5 Participants

PRIMARY outcome

Timeframe: 6 months after delivery

Population: IUD use at 6 months, lost to follow-up counted as failures

Usage rate of the LNG-IUD at 6 months after delivery

Outcome measures

Outcome measures
Measure
Postplacental IUD Insertion
n=51 Participants
Postplacental LNG-IUD insertion
Delayed IUD Insertion
n=51 Participants
Delayed LNG-IUD insertion
IUD Usage Rate at 6 Months
43 participants
39 participants

SECONDARY outcome

Timeframe: 6 months

Outcome measures

Outcome measures
Measure
Postplacental IUD Insertion
n=51 Participants
Postplacental LNG-IUD insertion
Delayed IUD Insertion
Delayed LNG-IUD insertion
Proportion of Women Who Are Able to Have the LNG-IUD Placed Postplacentally and Are Not Excluded From Placement
50 participants

SECONDARY outcome

Timeframe: 6 months

Outcome measures

Outcome measures
Measure
Postplacental IUD Insertion
n=51 Participants
Postplacental LNG-IUD insertion
Delayed IUD Insertion
Delayed LNG-IUD insertion
Follow-up Rates for Delayed Insertion of LNG-IUD
46 participants

SECONDARY outcome

Timeframe: 6 months

Population: The population only includes women who received IUDs at the specified timepoint. Only 50/51 women in the postplacental group had a successful IUD insertion postplacentally. Only 46 of 51 women in the delayed group returned for a delayed IUD insertion.

Outcome measures

Outcome measures
Measure
Postplacental IUD Insertion
n=50 Participants
Postplacental LNG-IUD insertion
Delayed IUD Insertion
n=46 Participants
Delayed LNG-IUD insertion
Expulsion Rates of Post-placental and Delayed Insertion of the LNG-IUD Using Clinical Exam and Ultrasonography
12 participants
2 participants

SECONDARY outcome

Timeframe: 6 months

Outcome measures

Outcome measures
Measure
Postplacental IUD Insertion
n=51 Participants
Postplacental LNG-IUD insertion
Delayed IUD Insertion
n=51 Participants
Delayed LNG-IUD insertion
Safety of Postplacental Insertion of the LNG-IUD as Measured by Infection Rates
1 participants
1 participants

SECONDARY outcome

Timeframe: 6 months

Outcome measures

Outcome measures
Measure
Postplacental IUD Insertion
n=41 Participants
Postplacental LNG-IUD insertion
Delayed IUD Insertion
n=41 Participants
Delayed LNG-IUD insertion
Rates of Follow-up and Unintended Pregnancy Rates for Subjects Who Are Excluded From Postpartum Insertion
2 participants
11 participants

Adverse Events

Postplacental IUD Insertion

Serious events: 1 serious events
Other events: 3 other events
Deaths: 0 deaths

Delayed IUD Insertion

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Serious adverse events
Measure
Postplacental IUD Insertion
n=51 participants at risk
Postplacental LNG-IUD insertion
Delayed IUD Insertion
n=51 participants at risk
Delayed LNG-IUD insertion
Social circumstances
death
2.0%
1/51 • Number of events 1 • 6 months
0.00%
0/51 • 6 months

Other adverse events

Other adverse events
Measure
Postplacental IUD Insertion
n=51 participants at risk
Postplacental LNG-IUD insertion
Delayed IUD Insertion
n=51 participants at risk
Delayed LNG-IUD insertion
Reproductive system and breast disorders
vaginal laceration
2.0%
1/51 • Number of events 1 • 6 months
0.00%
0/51 • 6 months
Reproductive system and breast disorders
retained IUD insertion tube
2.0%
1/51 • Number of events 1 • 6 months
0.00%
0/51 • 6 months
Reproductive system and breast disorders
malpositioned IUD
2.0%
1/51 • Number of events 1 • 6 months
0.00%
0/51 • 6 months

Additional Information

Principal Investigator

University of Pittsburgh

Phone: 412-641-5496

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place